Multiple myeloma trials in Georgia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  Where

  Tbilisi

  Age

  18 years and over

  People

  258 worldwide

  Run by

  Shanghai Henlius Biotech

  See details and how to joinNCT07477587